Patent ID: 8871752
Filing Date: 2014-10-28
Classification: A61K,A61P,C07C

Abstract:
1. A method for treating a disease or condition selected from the group consisting of osteoporosis, bone fracture, alveolar bone regeneration and anaplastic anemia in a mammalian subject, which comprises administering to the subject in need thereof an effective amount of a prostaglandin compound represented by the formula (I): wherein L, M and N are hydrogen atom, hydroxy, halogen atom, lower alkyl, hydroxy(lower)alkyl, lower alkanoyloxy or oxo, wherein at least one of L and M is a group other than hydrogen, and the five-membered ring may have at least one double bond; A is —CH B is single bond, —CH Z is or single bond wherein R R Ra is a saturated or unsaturated lower or medium aliphatic hydrocarbon residue, which is unsubstituted or substituted with halogen, oxo, hydroxy, lower alkyl, lower alkoxy, lower alkanoyloxy, cyclo(lower)alkyl, cyclo(lower)alkyloxy, aryl, aryloxy, heterocyclic group or hetrocyclic-oxy group; lower alkoxy; lower alkanoyloxy; cyclo(lower)alkyl; cyclo(lower)alkyloxy; aryl; aryloxy; heterocyclic group; heterocyclic-oxy.